Effects of a 16-week home-based exercise training programme on health-related quality of life, functional capacity, and persistent symptoms in survivors of severe/critical COVID-19 : a randomised controlled trial
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ..
BACKGROUND: Long-lasting effects of COVID-19 may include cardiovascular, respiratory, skeletal muscle, metabolic, psychological disorders and persistent symptoms that can impair health-related quality of life (HRQoL). We investigated the effects of a home-based exercise training (HBET) programme on HRQoL and health-related outcomes in survivors of severe/critical COVID-19.
METHODS: This was a single-centre, single-blinded, parallel-group, randomised controlled trial. Fifty survivors of severe/critical COVID-19 (5±1 months after intensive care unit discharge) were randomly allocated (1:1) to either a 3 times a week (~60-80 min/session), semi-supervised, individualised, HBET programme or standard of care (CONTROL). Changes in HRQoL were evaluated through the 36-Item Short-Form Health Survey, and physical component summary was predetermined as the primary outcome. Secondary outcomes included cardiorespiratory fitness, pulmonary function, functional capacity, body composition and persistent symptoms. Assessments were performed at baseline and after 16 weeks of intervention. Statistical analysis followed intention-to-treat principles.
RESULTS: After the intervention, HBET showed greater HRQoL score than CONTROL in the physical component summary (estimated mean difference, EMD: 16.8 points; 95% CI 5.8 to 27.9; effect size, ES: 0.74), physical functioning (EMD: 22.5 points, 95% CI 6.1 to 42.9, ES: 0.83), general health (EMD: 17.4 points, 95% CI 1.8 to 33.1, ES: 0.73) and vitality (EMD: 15.1 points, 95% CI 0.2 to 30.1, ES: 0.49) domains. 30-second sit-to-stand (EMD: 2.38 reps, 95% CI 0.01 to 4.76, ES: 0.86), and muscle weakness and myalgia were also improved in HBET compared with CONTROL (p<0.05). No significant differences were seen in the remaining variables. There were no adverse events.
CONCLUSION: HBET is an effective and safe intervention to improve physical domains of HRQoL, functional capacity and persistent symptoms in survivors of severe/critical COVID-19.
TRIAL REGISTRATION NUMBER: NCT04615052.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
---|---|
Enthalten in: |
British journal of sports medicine - 57(2023), 20 vom: 08. Okt., Seite 1295-1303 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Longobardi, Igor [VerfasserIn] |
---|
Links: |
---|
Themen: |
Covid-19 |
---|
Anmerkungen: |
Date Completed 09.10.2023 Date Revised 18.10.2023 published: Print-Electronic ClinicalTrials.gov: NCT04615052 Citation Status MEDLINE |
---|
doi: |
10.1136/bjsports-2022-106681 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356675319 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356675319 | ||
003 | DE-627 | ||
005 | 20231226070949.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/bjsports-2022-106681 |2 doi | |
028 | 5 | 2 | |a pubmed24n1188.xml |
035 | |a (DE-627)NLM356675319 | ||
035 | |a (NLM)37164620 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Longobardi, Igor |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effects of a 16-week home-based exercise training programme on health-related quality of life, functional capacity, and persistent symptoms in survivors of severe/critical COVID-19 |b a randomised controlled trial |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.10.2023 | ||
500 | |a Date Revised 18.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a ClinicalTrials.gov: NCT04615052 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a BACKGROUND: Long-lasting effects of COVID-19 may include cardiovascular, respiratory, skeletal muscle, metabolic, psychological disorders and persistent symptoms that can impair health-related quality of life (HRQoL). We investigated the effects of a home-based exercise training (HBET) programme on HRQoL and health-related outcomes in survivors of severe/critical COVID-19 | ||
520 | |a METHODS: This was a single-centre, single-blinded, parallel-group, randomised controlled trial. Fifty survivors of severe/critical COVID-19 (5±1 months after intensive care unit discharge) were randomly allocated (1:1) to either a 3 times a week (~60-80 min/session), semi-supervised, individualised, HBET programme or standard of care (CONTROL). Changes in HRQoL were evaluated through the 36-Item Short-Form Health Survey, and physical component summary was predetermined as the primary outcome. Secondary outcomes included cardiorespiratory fitness, pulmonary function, functional capacity, body composition and persistent symptoms. Assessments were performed at baseline and after 16 weeks of intervention. Statistical analysis followed intention-to-treat principles | ||
520 | |a RESULTS: After the intervention, HBET showed greater HRQoL score than CONTROL in the physical component summary (estimated mean difference, EMD: 16.8 points; 95% CI 5.8 to 27.9; effect size, ES: 0.74), physical functioning (EMD: 22.5 points, 95% CI 6.1 to 42.9, ES: 0.83), general health (EMD: 17.4 points, 95% CI 1.8 to 33.1, ES: 0.73) and vitality (EMD: 15.1 points, 95% CI 0.2 to 30.1, ES: 0.49) domains. 30-second sit-to-stand (EMD: 2.38 reps, 95% CI 0.01 to 4.76, ES: 0.86), and muscle weakness and myalgia were also improved in HBET compared with CONTROL (p<0.05). No significant differences were seen in the remaining variables. There were no adverse events | ||
520 | |a CONCLUSION: HBET is an effective and safe intervention to improve physical domains of HRQoL, functional capacity and persistent symptoms in survivors of severe/critical COVID-19 | ||
520 | |a TRIAL REGISTRATION NUMBER: NCT04615052 | ||
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Covid-19 | |
650 | 4 | |a Fatigue | |
650 | 4 | |a Physical activity | |
650 | 4 | |a Quality of life | |
650 | 4 | |a Rehabilitation | |
700 | 1 | |a Goessler, Karla |e verfasserin |4 aut | |
700 | 1 | |a de Oliveira Júnior, Gersiel Nascimento |e verfasserin |4 aut | |
700 | 1 | |a Prado, Danilo Marcelo Leite do |e verfasserin |4 aut | |
700 | 1 | |a Santos, Jhonnatan Vasconcelos Pereira |e verfasserin |4 aut | |
700 | 1 | |a Meletti, Matheus Molina |e verfasserin |4 aut | |
700 | 1 | |a de Andrade, Danieli Castro Oliveira |e verfasserin |4 aut | |
700 | 1 | |a Gil, Saulo |e verfasserin |4 aut | |
700 | 1 | |a Boza, João Antonio Spott de Oliveira |e verfasserin |4 aut | |
700 | 1 | |a Lima, Fernanda Rodrigues |e verfasserin |4 aut | |
700 | 1 | |a Gualano, Bruno |e verfasserin |4 aut | |
700 | 1 | |a Roschel, Hamilton |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t British journal of sports medicine |d 1974 |g 57(2023), 20 vom: 08. Okt., Seite 1295-1303 |w (DE-627)NLM000126225 |x 1473-0480 |7 nnns |
773 | 1 | 8 | |g volume:57 |g year:2023 |g number:20 |g day:08 |g month:10 |g pages:1295-1303 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/bjsports-2022-106681 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 57 |j 2023 |e 20 |b 08 |c 10 |h 1295-1303 |